X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6250) 6250
Book Chapter (62) 62
Magazine Article (10) 10
Book / eBook (2) 2
Dissertation (2) 2
Book Review (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5601) 5601
female (4025) 4025
thrombophilia (2581) 2581
adult (2501) 2501
male (2485) 2485
index medicus (2434) 2434
risk factors (2035) 2035
hematology (1985) 1985
pregnancy (1838) 1838
thrombophilia - complications (1829) 1829
middle aged (1742) 1742
thrombosis (1529) 1529
peripheral vascular disease (1342) 1342
thrombophilia - genetics (1220) 1220
thrombophilia - etiology (1212) 1212
aged (1090) 1090
mutation (1048) 1048
factor-v-leiden (991) 991
anticoagulants - therapeutic use (978) 978
risk (886) 886
venous thromboembolism (885) 885
factor v - genetics (873) 873
thrombophilia - blood (862) 862
adolescent (850) 850
thromboembolism (803) 803
venous thrombosis (788) 788
thrombophilia - diagnosis (787) 787
thrombophilia - drug therapy (740) 740
obstetrics & gynecology (600) 600
case-control studies (599) 599
activated protein-c (598) 598
women (591) 591
prevalence (581) 581
venous thrombosis - etiology (577) 577
prothrombin - genetics (570) 570
risk-factors (542) 542
retrospective studies (533) 533
child (512) 512
thrombophilia - epidemiology (488) 488
thrombosis - etiology (488) 488
young adult (478) 478
prospective studies (461) 461
deep-vein thrombosis (456) 456
coagulation (433) 433
anticoagulants (426) 426
inherited thrombophilia (422) 422
aged, 80 and over (413) 413
medicine, general & internal (399) 399
surgery (391) 391
recurrence (389) 389
disease (380) 380
genetic predisposition to disease (370) 370
treatment outcome (367) 367
infant, newborn (356) 356
molecular-weight heparin (352) 352
complications (351) 351
resistance (338) 338
child, preschool (321) 321
factor v leiden (318) 318
pediatrics (312) 312
preeclampsia (309) 309
stroke (309) 309
antiphospholipid antibodies (305) 305
medicine & public health (303) 303
incidence (298) 298
pregnancy outcome (297) 297
thromboembolism - etiology (296) 296
anticoagulants - administration & dosage (288) 288
heparin, low-molecular-weight - therapeutic use (285) 285
abridged index medicus (282) 282
antiphospholipid syndrome (280) 280
prothrombin (272) 272
children (271) 271
heparin (264) 264
methylenetetrahydrofolate reductase - genetics (264) 264
follow-up studies (263) 263
prevention (260) 260
venous thrombosis - genetics (260) 260
risk assessment (256) 256
infant (251) 251
heterozygote (247) 247
point mutation (247) 247
venous thrombosis - epidemiology (247) 247
thrombophilia - physiopathology (246) 246
protein c (244) 244
diagnosis (243) 243
genotype (243) 243
blood coagulation tests (242) 242
pregnant women (242) 242
anticoagulants - adverse effects (240) 240
cohort studies (240) 240
thrombin (238) 238
cardiac & cardiovascular systems (235) 235
health aspects (235) 235
antiphospholipid syndrome - complications (234) 234
care and treatment (234) 234
pulmonary-embolism (234) 234
analysis (233) 233
fetal loss (233) 233
hemostasis (230) 230
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5576) 5576
Spanish (192) 192
French (161) 161
Russian (112) 112
German (103) 103
Italian (43) 43
Polish (34) 34
Czech (27) 27
Japanese (25) 25
Bulgarian (21) 21
Portuguese (16) 16
Hungarian (9) 9
Chinese (8) 8
Croatian (8) 8
Dutch (8) 8
Danish (7) 7
Ukrainian (5) 5
Serbian (4) 4
Hebrew (3) 3
Swedish (3) 3
Finnish (2) 2
Turkish (2) 2
Korean (1) 1
Norwegian (1) 1
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Stroke, ISSN 0039-2499, 01/2011, Volume 42, Issue 1, pp. 227 - 276
The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of ischemic stroke among survivors of... 
AHA scientific statements | Stroke | Stroke prevention | Transient ischemic attack | Ischemia | ACTIVATED PROTEIN-C | PATENT FORAMEN OVALE | transient ischemic attack | DENSITY-LIPOPROTEIN-CHOLESTEROL | LEFT-VENTRICULAR THROMBI | stroke | CLINICAL NEUROLOGY | AHA Scientific Statements | ischemia | FACTOR-V-LEIDEN | CLINICAL-CARDIOLOGY-SUBCOMMITTEE | SICKLE-CELL-ANEMIA | BODY-MASS INDEX | PERIPHERAL VASCULAR DISEASE | stroke prevention | INTERNAL CAROTID-ARTERY | INDEPENDENT RISK-FACTOR | Recurrence | Thrombophilia - therapy | Ischemic Attack, Transient - therapy | Embolism - therapy | Thrombosis - complications | Humans | Hyperhomocysteinemia - therapy | Male | Thrombophilia - complications | Ischemic Attack, Transient - complications | Atherosclerosis - therapy | Heart Diseases - complications | Cerebral Hemorrhage - therapy | Female | Platelet Aggregation Inhibitors - therapeutic use | Thrombosis - therapy | Platelet Aggregation Inhibitors - adverse effects | Pregnancy Complications, Cardiovascular - therapy | Stroke - prevention & control | Foramen Ovale, Patent - therapy | Embolism - complications | Anemia, Sickle Cell - complications | Risk Factors | Anticoagulants - therapeutic use | Atherosclerosis - complications | Anticoagulants - adverse effects | Evidence-Based Medicine | Pregnancy | Anemia, Sickle Cell - therapy | Stroke - etiology | Heart Diseases - therapy | Foramen Ovale, Patent - complications | Cerebral Hemorrhage - complications | Hyperhomocysteinemia - complications
Journal Article
Journal of Diabetes and Its Complications, ISSN 1056-8727, 2016, Volume 30, Issue 4, pp. 738 - 745
Abstract Background Vascular complications are the leading cause of morbidity and mortality among patients with type 1 and type 2 diabetes mellitus... 
Endocrinology & Metabolism | vascular complications | hypercoagulability | inflammation | endothelial dysfunction | Diabetes mellitus | FACTOR-VIII | MARKERS | MICROVASCULAR COMPLICATIONS | VON-WILLEBRAND-FACTOR | URINARY ALBUMIN EXCRETION | VONWILLEBRAND-FACTOR | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | ASSOCIATION | D-DIMER | Vasculitis - metabolism | Oxidative Stress | Vasculitis - physiopathology | Humans | Diabetes Mellitus, Type 1 - metabolism | Diabetes Mellitus, Type 1 - complications | Diabetes Mellitus, Type 2 - metabolism | Thrombophilia - complications | Vasculitis - complications | Vasculitis - immunology | Thrombophilia - immunology | Diabetic Angiopathies - physiopathology | Diabetes Mellitus, Type 2 - immunology | Diabetic Angiopathies - complications | Diabetes Mellitus, Type 1 - immunology | Diabetes Mellitus, Type 2 - complications | Endothelium, Vascular - immunology | Diabetic Angiopathies - metabolism | Thrombophilia - physiopathology | Diabetes Mellitus, Type 1 - physiopathology | Endothelium, Vascular - physiopathology | Biomarkers - blood | Animals | Diabetes Mellitus, Type 2 - physiopathology | Endothelium, Vascular - metabolism | Models, Biological | Diabetic Angiopathies - immunology | Thrombophilia - metabolism | Type 2 diabetes | Oxidative stress | Complications and side effects | Inflammation | Index Medicus
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2014, Volume 2014, Issue 7, p. CD004734
Background Since hypercoagulability might result in recurrent miscarriage, anticoagulant agents could potentially increase the chance of live birth in... 
Anticoagulants | Antiphospholipid Syndrome | Aspirin | Pregnancy Complications, Hematologic | Live Birth | Pregnancy & childbirth | Enoxaparin | Heparin, Low‐Molecular‐Weight | Randomized Controlled Trials as Topic | Thrombophilia | Prevention | Nadroparin | Medicine General & Introductory Medical Sciences | Miscarriage | Abortion, Habitual | PHOSPHOLIPID ANTIBODIES | Abortion, Habitual [drug therapy; etiology] | BONE-MINERAL DENSITY | PLUS HEPARIN | Aspirin [therapeutic use] | Humans | ANTIPHOSPHOLIPID ANTIBODIES | RANDOMIZED CONTROLLED-TRIAL | PREGNANCY LOSS | PROTEIN-C | Pregnancy | MEDICINE, GENERAL & INTERNAL | Pregnancy Complications, Hematologic [drug therapy; etiology] | LOW-DOSE ASPIRIN | Antiphospholipid Syndrome [complications] | FETAL LOSS | MOLECULAR-WEIGHT HEPARIN | Female | Heparin, Low-Molecular-Weight [therapeutic use] | Thrombophilia [complications; drug therapy] | Anticoagulants [therapeutic use] | Anticoagulants - therapeutic use | Enoxaparin - therapeutic use | Antiphospholipid Syndrome - complications | Heparin, Low-Molecular-Weight - therapeutic use | Thrombophilia - complications | Pregnancy Complications, Hematologic - drug therapy | Nadroparin - therapeutic use | Abortion, Habitual - blood | Abortion, Habitual - prevention & control | Aspirin - therapeutic use | Pregnancy Complications, Hematologic - etiology | Abortion, Habitual - etiology | Thrombophilia - drug therapy
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9955, pp. 1673 - 1683
Journal Article
Hematology, ISSN 1520-4391, 2014, Volume 2014, Issue 1, pp. 393 - 399
Women with acquired and inherited thrombophilia are thought to be at increased risk for pregnancy complications, including recurrent pregnancy loss and, depending on the type of thrombophilia, severe preeclampsia... 
WOMEN | RECURRENT MISCARRIAGE | LOW-DOSE ASPIRIN | PLUS HEPARIN | MOLECULAR-WEIGHT HEPARIN | THROMBOPHILIA | PREVENTION | PREECLAMPSIA | RANDOMIZED CONTROLLED-TRIAL | HEMATOLOGY | EDUCATION, SCIENTIFIC DISCIPLINES | ANTIPHOSPHOLIPID SYNDROME | Pregnancy | Blood Coagulation - drug effects | Humans | Adult | Anticoagulants - therapeutic use | Female | Clinical Trials as Topic | Drug Prescriptions | Thrombophilia - complications | Pregnancy Complications, Hematologic - drug therapy
Journal Article